PHIO Q1 2026 Earnings EPS Misses Estimates Amid Continued Clinical Trials Focus USFD Q1 2026 Earnings Earnings Miss Estimates Amid Challenging Environment Fulcrum Therapeutics Q1 2026 Earnings Narrowed Loss Exceeds Analyst Expectations DFTX Q1 2026 Earnings Missed EPS Estimates as Pipeline Costs Weigh on Results Norfolk Southern Q1 2026 Earnings EPS Beat Lifts Shares Despite Macro Headwinds SAN Q1 2026 Earnings EPS Surpasses Estimates by Over 31 Shares Dip Slightly